This article is currently slated for merging. After a discussion, consensus to merge this article into Sputnik V COVID-19 vaccine was found. You can help implement the merge by following the instructions at Help:Merging and the resolution on the discussion. Process started in December 2021. |
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Viral vector |
Clinical data | |
Routes of administration | Intramuscular |
ATC code | |
Legal status | |
Legal status |
|
Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
Sputnik Light (Russian: Спутник Лайт, romanized: Sputnik Layt or Lajt[1]) is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.[2] It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector, and it can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F).[3] The institute says this version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly.[4] It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier.[5]